LOS ANGELES, Sept 29 (Reuters) - The U.S. Food and Drug Administration has warned Gilead Sciences Inc (GILD.O) about manufacturing problems at the San Dimas, California plant where drugs including the company’s flagship HIV medicines are made.
LOS ANGELES, Sept 29 (Reuters) - The U.S. Food and Drug Administration has warned Gilead Sciences Inc (GILD.O) about manufacturing problems at the San Dimas, California plant where drugs including the company’s flagship HIV medicines are made.
